Moteur de recherche d’entreprises européennes
Financement de l’UE (9 998 845 €) : Infrastructures de recherche pour la lutte contre les maladies à transmission vectorielle Hor01/02/2017 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Infrastructures de recherche pour la lutte contre les maladies à transmission vectorielle
The overall objective of the Infravec2 project is to integrate key specialized research facilities necessary for European excellence in insect vector biology, to open the infrastructure for European access, and to develop new vector control measures targeting the greatest threats to human health and animal industries. Infravec2 is an Advanced Community, following a four-year Starting Community lifecycle (FP7 Infravec1). Lack of access to key infrastructures limits European vector research and impedes development of vector control measures. Insect vectors transmit parasitic diseases such as malaria and leishmaniasis, and viral infections such as chikungunya, dengue, Zika, Japanese encephalitis and yellow fever. Vector-borne diseases, which have historically been a problem of tropical countries, now represent a threat for temperate regions of the world including much of Europe. The 24 consortium partners, including 4 commercial companies, hold the major European biosecure insectaries for experimental infection and containment of insect vectors under Containment Level 2 and 3 (CL2/CL3) conditions, other key insect vector facilities, and include front-line field sites in Africa, the Pacific, and the Americas. Infravec2 will implement comparable standards across the secure insectary facilities as a world first, improving exploitation of European vector infrastructures for research and public health, and will develop other innovative methodologies and technologies. Networking activities will assure that the project achieves full impact, producing a step change in European vector biology research and the product pipeline, and consolidating European global leadership in insect vectors. The goal of the Infravec2 project is to build a durable European infrastructure to control insect vector-borne disease, including with power to predict and prevent the inevitable next epidemic outbreak in advance.
| Centre de Cooperation Internationale en Recherche Agronomique Pour Ledeveloppement - C.I.R.A.D. Epic | 226 652 € |
| 278 890 € | |
| 376 680 € | |
| Fondation Health Sciences e-Training | 274 789 € |
| 680 888 € | |
| Imperial College of Science Technology and Medicine | 762 346 € |
| Institut Pasteur | 1 275 930 € |
| Institut Pasteur DE Dakar | 101 250 € |
| 92 527 € | |
| Institut de Recerca i Tecnologia Agroalimentaries | 375 923 € |
| Institut de Recherche Pour le Developpement | 912 055 € |
| Liverpool School of Tropical Medicine | 62 813 € |
| MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN e. V. | 473 438 € |
| 104 260 € | |
| Polo D'Innovazione DI Genomica, Genetica E Biologia Srl | 960 581 € |
| Stichting Radboud Universitair Medisch Centrum | 316 185 € |
| 0,00 € | |
| The Pirbright Institute LBG | 559 983 € |
| 415 400 € | |
| 324 043 € | |
| 101 000 € | |
| University of Glasgow | 481 150 € |
| 607 750 € | |
| 45 613 € | |
| 188 702 € |
https://cordis.europa.eu/project/id/731060
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "Centre de Cooperation Internationale en Recherche Agronomique Pour Ledeveloppement - C.I.R.A.D. Epic - Financement de l’UE (9 998 845 €) : Infrastructures de recherche pour la lutte contre les maladies à transmission vectorielle"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
